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Abstract 
In the present work, nickel magnetic nanoparticles with diameters lower than 100 nm, 
with and without silica shell, were synthesized by microheterogeneous templating. The 
magnetic properties of the nanoparticles show a typical ferromagnetic behavior with a 
coercive field of 80Oe. Dry magnetoliposomes (DMLs) with diameter between 58nm 
and 76nm were obtained from the synthesis of nanoparticles in the presence of a lipid or 
surfactant layer, and aqueous magnetoliposomes (AMLs) were obtained by 
encapsulation of the nanoparticles in liposomes. FRET (Förster resonance energy 
transfer) experiments were performed to study the non-specific interactions between 
aqueous magnetoliposomes and giant unilamellar vesicles (GUVs), as models of cell 
membranes. It was possible to detect membrane fusion between GUVs and AMLs 
containing both NBD-C6-HPC (donor) and the dye Nile Red (acceptor).  
  
Highlights 
1. Magnetic nickel nanoparticles were synthesized in microheterogeneous media. 
2. The nanoparticles were covered with a silica shell to improve biocompatibility. 
3. Aqueous and dry magnetoliposomes were prepared, the latter with diameter 
around 70 nm.  
4. Membrane fusion between magnetoliposomes and models of cell membranes 
was detected by FRET. 
 
Keywords 
Nanostructures; magnetic materials; interfaces; light scattering; photoluminescence 
spectroscopy; magnetic properties. 
 
1. Introduction 
Nanotechnology has produced significant advances in biomedicine, namely in 
diagnosis, therapy and bioengineering [1]. The potential of magnetic nanoparticles for 
biomedical applications has been recognized, as they offer major advantages due to 
their unique size and physicochemical properties [2].  
Liposomes (nanosized vesicles made of amphiphilic phospholipid molecules in water) 
are biologically inert and weakly immunogenic, and have been described as ideal drug 
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delivery systems [3-5]. This nanoencapsulation system can overcome many of the 
problems associated with other systems used for therapy, such as those involving 
solubility, pharmacokinetics, in vivo stability and toxicity [6,7]. Liposomes entrapping 
magnetic nanoparticles (magnetoliposomes) are of large importance in drug delivery, as 
they can be guided and localized to the therapeutic site of interest by external magnetic 
field gradients and used in cancer treatment by hyperthermia [8,9]. In diagnosis, 
magnetoliposomes have been proposed as T2 contrast agents (negative contrast 
enhancement) in MRI [10], while in therapy they have been used as a chemotherapy 
alternative through magnetic-controlled drug delivery and thermotherapy [11-13].  
In biomedicine, nanoparticles with superparamagnetic behavior are preferred, as they 
exhibit a strong magnetization only when an external magnetic field is applied 
[5,14,15]. Iron and nickel nanoparticles are superparamagnetic when their size is 
smaller than a critical value, 20 nm for iron [16] and 30 nm for nickel [17]. Due to the 
wide applications of magnetoliposomes, much attention has been paid to the synthesis 
of different kinds of magnetic nanoparticles [18-20] and liposomes [14,21-23], as each 
potential application requires specific properties. 
Nickel exhibits magnetic properties at room temperature and, therefore, is considered a 
metal of biological interest. However, particles of nickel have some issues such as 
potential toxicity, high reactivity and easy degradation due to the high surface/volume 
ratio. In order to overcome these problems and make them compatible for biological 
applications, nickel magnetic nanoparticles are typically protected by coatings, such as 
gold or silica, forming a core-shell structure [18,24,25]. Silica is a particular beneficial 
coating for nanoparticles, since it can easily be functionalized and it is resistant to 
degradation within a cellular environment, whilst still being biocompatible [26,27]. In 
fact, previous studies have shown that internalized silica-coated magnetic nanoparticles 
are biocompatible with stem cells [26,27]. 
The synthesis methods of magnetoliposomes and their constituents will determine their 
final shape, size distribution, surface chemistry and magnetic properties [15,28]. 
Techniques for magnetic nanoparticle synthesis have been developed to yield nearly 
monodisperse colloids, consisting of uniform nanoparticles both in size and shape. In 
these systems, the entire uniform physicochemical properties directly reflect the 
properties of single particles [29,30]. 
In this work, both aqueous and dry magnetoliposomes, based on nickel nanoparticles or 
nickel/silica core/shell nanoparticles were prepared by several soft templating methods 
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and characterized. The interaction between the prepared magnetoliposomes and models 
of cell membranes (giant unilamellar vesicles, GUVs) was also evaluated using FRET 
(Förster Resonance Energy Transfer). These studies are important for future drug 
delivery applications using magnetoliposomes as drug carriers. 
 
2. Experimental 
All the solutions were prepared using spectroscopic grade solvents and ultrapure water 
(Milli-Q grade). 
 
2.1 Nickel nanoparticles preparation 
Ni nanoparticles (NPs) were prepared using a Nickel chloride (Merck) stock solution 
(~0.2 M). For Ni
2+
 reduction, hydrazine monohydrate (N2H4H2O) 64-65% and sodium 
hydroxide solution (NaOH, 50% in water), from Sigma-Aldrich, were used as received. 
Citric acid (Merck) was added in some assays in a molar ratio 1:0.75, as it prevents 
nanoparticles aggregation and favours monodispersity [28]. 
 
2.1.1 Ni NPs in aqueous CTAB solution 
CTAB (cetyltrimethylammonium bromide) was obtained from Sigma-Aldrich. Ni NPs 
were synthesized in an aqueous solution of this cationic surfactant, according to a 
procedure adapted from [31]. An aqueous solution of CTAB (0.025 M), nickel chloride 
(0.02 M) and trace acetone (10 µL/ml) was first prepared. Then, 1M of N2H4 and 10M 
NaOH solution were added in sequence. After 30 minutes at 60 ºC, Ni NPs were 
formed. 
 
2.1.2 Ni NPs coated with lipid or double-chain surfactant 
AOT (bis(2-ethylhexyl)sulfosuccinate) sodium salt from Sigma-Aldrich and DOPG 
(1,2-Dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]), from Avanti Polar Lipids, were 
used to control NPs size growth [32]. Ni NPs coated with a layer of AOT or DOPG 
molecules were synthesized by carrying out the reduction of nickel chloride in the 
presence of lipid/surfactant molecules. An experimental procedure previously described 
by Meledandri et al. [33] was followed. One fifth of the total DOPG amount (0.2 mM 
DOPG) was slowly added to a 1 mM nickel chloride aqueous solution under magnetic 
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stirring, followed by the addition of 0.9 M N2H4 and 13 M NaOH to precipitate the 
nickel. After 5 minutes, the remaining DOPG (0.8 mM) was slowly added to the 
mixture. After about 20 minutes at 60 ºC, Ni NPs covered by a DOPG layer were 
obtained [33].  
Ni NPs covered with an AOT layer were synthesized by a similar procedure using a 
56mM solution of AOT in methanol. After about 20 minutes, under vigorous magnetic 
stirring at 60 ºC, NPs were formed. After cooling, Ni NPs were washed by magnetic 
decantation with methanol/acetone (50/50 v/v) solution and dispersed in water. 
 
2.1.3 NPs with silica shell 
The synthesized NPs were covered with a silica shell obtained by TEOS (tetraethyl 
orthosilicate, from Sigma Aldrich) hydrolysis. Different shell sizes were achieved by 
the addition of different amounts of TEOS into a solution of nanoparticles dispersed 
either in AOT/cyclohexane (0.1M) or in ethanol [34]. In the latter method, MDA 
(mercaptododecanoic acid) was added to the particles in a 1:1 ratio to promote TEOS 
binding to the nanoparticles. 
 
2.2 Preparation of magnetoliposomes 
Aqueous magnetoliposomes (AMLs) are formed when the magnetic nanoparticles are 
encapsulated in liposomes. Both dipalmitoyl phosphatidylcholine (DPPC) and egg yolk 
phosphatidylcholine (Egg-PC), from Sigma-Aldrich, were used for lipid vesicle 
formation. A 10 mM DPPC or Egg-PC solution in ethanol was injected, under vigorous 
vortexing, to an aqueous solution of nanoparticles, above the melting transition 
temperature of the lipids (ethanolic injection method [33,36]). After encapsulation, the 
ferrofluid was washed with water and purified by magnetic decantation and 
centrifugation to remove all the non-encapsulated NPs. 
Dry magnetoliposomes (DMLs) were synthesized by slowly adding a volume of DOPG 
or AOT solution, equivalent to that used in the synthesis of the NPs coated with lipid or 
surfactant, so that a second lipid/surfactant layer is formed above the previous layer. 
Excess of lipid/surfactant was removed by repeated cycles of magnetic decantation 
followed by washing with methanol/acetone (50/50 v/v) solution. 
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2.3 Preparation of Giant Unilamellar Vesicles (GUVs) 
Soybean lecithin (L-α-Phosphatidylcholine), from Sigma-Aldrich, was used for GUVs 
preparation, using a procedure previously described [37,38]. A film of soybean lecithin 
was obtained by evaporation under an argon stream of a 1 mM lipid solution. This film 
was incubated with 20 L of water at 45 ºC for 45 minutes. Then, 3 mL of 0.1 M 
glucose solution was added, and the resulting mixture was again incubated at 37 ºC.  
 
2.4 Spectroscopic measurements 
2.4.1 General methods 
Absorption spectra were recorded in a Shimadzu UV-3101PC UV-vis-NIR 
spectrophotometer. Fluorescence measurements were performed using a Fluorolog 3 
spectrofluorimeter, equipped with double monochromators in both excitation and 
emission and a temperature controlled cuvette holder. Fluorescence spectra were 
corrected for the instrumental response of the system.  
 
2.4.2 FRET measurements 
The interaction of magnetoliposomes with models of biological membranes (GUVs) 
was evaluated by Förster Resonance Energy Transfer (FRET). FRET efficiency, ΦRET, 
defined as the proportion of donor molecules that have transferred their excess energy to 
acceptor molecules, was calculated through donor emission quenching, by taking the 
ratio of the donor integrated fluorescence intensities in the presence of acceptor and in 
the absence of acceptor [39]. The distance between donor and acceptor molecules was 
determined through the FRET efficiency (equation 1),  
    𝑟 =  𝑅0. [
1−ΦRET
ΦRET
]
1
6⁄
                          (1) 
where R0 is the Förster radius (critical distance), that can be obtained by the spectral 
overlap between the donor emission and the acceptor absorption [39].  
FRET assays were employed to confirm the formation of the second lipid bilayer in the 
dry magnetoliposomes (DMLs). For that purpose, the rhodamine B labeled lipid 
Rhodamine-DHPE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine 
rhodamine B sulfonyl) (ammonium salt) (from Avanti Polar Lipids, structure shown 
below – Figure 1) was included the first lipid layer, while the nitrobenzoxazole labeled 
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lipid NBD-C6-HPC (1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]hexanoyl}-sn-glycero-3-phosphocholine) (from Avanti Polar Lipids, Figure 1) 
was included in the second lipid layer.  
For the study of the interaction of magnetoliposomes with GUVs, the former were 
labeled with both NBD-C6-HPC and the hydrophobic probe Nile Red (from Fluka, 
structure in Figure 1). 
 
 
 
 
 
 
 
 
 
Figure 1 – Structures of the fluorescent labeled lipids and the dye Nile Red. 
 
The fluorescence quantum yield, s, of the energy donor (in both cases, the dye NBD) 
in magnetoliposomes was determined by the standard method (equation 2) [40,41], 
      rs  2
2
rrs
ssr
nFA
nFA
        (2) 
where A is the absorbance at the excitation wavelength, F the integrated emission area 
and n the refraction index of the solvents used. Subscripts refer to the reference (r) or 
sample (s). The absorbance at the excitation wavelength was always lower than 0.1 to 
avoid the inner filter effects. The NBD-C6-HPC molecule intercalated in lipid 
membranes was used as reference, r=0.32 at 25 ºC, as reported by Invitrogen [42]. 
2.5 Structural and magnetic characterization 
Scanning electron microscopy (SEM) images of nickel nanoparticles and dry 
magnetoliposomes were recorded using a Scanning Electron Microscope FEI - Nova 
200 NanoSEM. The processing of SEM images was performed using ImageJ software. 
Rhodamine-DHPE 
NBD-C6-HPC Nile Red 
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It consisted in enhancing local contrast followed by automatic local thresholding and 
particle analysis. The area of each particle allowed an estimation of the particle 
diameter. The resulting histograms were fitted to Gaussian distributions. 
Magnetic hysteresis cycles of nickel NPs were measured at room temperature in a 
Superconducting Quantum Interference Device (SQUID) magnetometer (Quantum 
Design MPMS5XL), with applied magnetic fields up to 5.5 T. 
NPs mean diameter and size distribution (polydispersity index) were measured using a 
Dynamic Light Scattering (DLS) equipment (NANO ZS Malvern Zetasizer) at 25 ºC, 
using a He-Ne laser of λ=632.8 nm and a detector angle of 173º. Five independent 
measurements were performed for each sample. 
The experimentally obtained intensity autocorrelation function, G
(2) 
(), has the form 
[43,44] 
     𝐺(2)() = 𝐴 [1 + 𝐵|𝑔(1)()|
2
]           (3) 
where A is the baseline, B is a spatial coherence factor,  is the delay time, and g(1)() is 
the first-order normalized electric field time correlation function. 
For a polydisperse system, g
(1)
() decays as a weighted sum of single exponentials. 
These weights are modeled by Gaussian distributions, such that  
𝑔(1)() = ∫ ∑
𝑎𝑖
𝜎𝑖√2𝜋
𝑖
∞
0
exp (− [
(s−s𝑖)
√2𝜎𝑖
]
2
)exp(−  𝑠⁄ ) ds        (4) 
where ai is the weight of each Gaussian population. 
The decay lifetime, s, depends on the translational diffusion coefficient, Dz, which can 
be related to the particle hydrodynamic diameter through the Stokes-Einstein equation. 
A “size distribution” can thus be obtained, which is represented by GI(d), as each 
particle population is weighted by the intensity of scattered light it originates. In order 
to obtain the real size distribution of the sample, in which each particle population is 
weighted by its number fraction, Gn(d), the variation of light scattering intensity with 
particle size (and shape) must be introduced [45], 
 𝐺𝐼(𝑑) = 𝐺𝑛(𝑑)𝐼𝑠(𝑑)             (5) 
where Is(d) is the scattered intensity per particle. 
For spherical particles, and in the case of Rayleigh regime (valid for 𝑥 = 𝜋𝑑 𝜆 ≪ 1⁄ ), 
this factor scales with d
6
. For situations where the refractive index of the particles and 
the medium are similar, the Rayleigh-Gans-Debye (RGD) theory is valid and the 
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scattering light intensity is proportional to the square of the particle volume and to a 
form factor, P(R)=f(R)
2
 [46]. For other situations, the value of Is(d) must be calculated 
using appropriate theories, such as Mie theory (spherical particles) or Aden-Kerker 
theory (spherical coated particles). 
 
3. Results and discussion 
3.1 Characterization of Ni nanoparticles 
3.1.1. Absorption spectra 
Figure 2 shows the absorption spectrum of nickel nanoparticles obtained from the 
synthesis in CTAB microemulsions, without (A) and with silica shell (B).  
Considering the reported cytotoxicity of Ni NPs for several human cell lines [47,48],  
the presence of the silica shell could be important for biomedical applications of these 
magnetic nickel nanoparticles. As referred, the biocompatibility of silica nanoparticles 
and magnetic nanoparticles with a silica-shell was previously demonstrated [26,27].  
The formation of Ni metal nanoparticles is confirmed by the absorption in the whole 
spectral range and plasmon absorption band at 288 nm (Figure 2). This plasmon 
absorption band is very sensitive to the local dielectric environment and results from a 
resonant coherent oscillation of the free electrons at the surface of a spherical NP (LSPR 
- localized surface plasmon resonance) that is induced by the electromagnetic field of 
incident light [49].  
 
Figure 2 – Absorption spectra of Ni@SiO2 nanoparticles dispersed in ethanol. The Ni cores were 
synthesized in aqueous CTAB solution. A: without silica shell; B: with silica shell added to Ni NPs 
dispersed in AOT/cyclohexane using different [TEOS]/[Ni] ratios. 
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Core-shell nickel nanoparticles with different silica shell sizes were formed by the 
addition of TEOS at several concentrations. A strong SPR enhancement is observed 
after coating (Figure 2B), indicating a change in the dielectric constant of the medium 
surrounding the NPs, confirming formation of the silica shell (Figure 2B). However, no 
further increase in absorption intensity was observed for [TEOS]/[Ni] molar ratio above 
30:1. This can be attributed to the method used for the formation of the silica shell. As 
TEOS is added to the Ni NPs dispersed in a AOT/cyclohexane solution, the sol-gel 
process occur within AOT reverse micelles. This can limit the shell growth. For gold 
nanoparticles, very small changes are observed in the plasmon band [50]. On the other 
hand, a band near 270 nm was reported for SiO2 nanoparticles obtained from sol-gel 
processing [51]. Thus, the huge absorbance increase upon coating of Ni NPs with SiO2 
should originate from absorption and/or scattering of the silica layer.    
 
3.1.2. DLS measurements 
DLS measurements revealed that particles size and size distribution are influenced by 
the synthesis method. Hydrodynamic diameters of Ni NPs with different [silica]/[Ni] 
ratios and without silica shell are shown in Table 1.  
The scattered light per particle, Is(d), needed to obtain the real size distributions from 
DLS data, was calculated using the equations proposed by Aden-Kerker [52] with a 
Fortran implementation developed by Quirantes et al. [53]. Figure 3 plots s11, an 
element of the scattering matrix (proportional to Is/I0 [46]), as function of particle 
diameter for unpolarized light of 632.8 nm at 173º scattering angle and a bulk refractive 
index of 1.36042 (ethanol at 25 ºC). For Ni NPs, a refractive index of m(Ni)=1.97006 + 
3.72121 i [54] was used. In the case of Ni@SiO2 core/shell NPs, a value of 1.45702 
[55] was used for the refractive index of silica, either considering a constant Ni core 
with a diameter of 100 nm, or a constant SiO2 shell of 50 nm thickness. For vesicles, a 
bilayer with 5 nm thickness was used with a refractive index of 1.435 [56]. 
It is observed that Rayleigh regime is only valid for Ni NPs up to 20 nm diameter. The 
RGD approximation is better, but the oscillations do not occur at the same particle sizes 
and the minima are much more pronounced. In the case of vesicles, the RGD 
approximation is quite good. 
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Figure 3 – S11 scattering matrix element for Ni NPs, Ni@SiO2 NPs and vesicles. 
 
The number weighted size distributions could then be obtained by fitting a Gaussian 
distribution to the calculated Gn(d) from equation (5). In the case of Ni@SiO2, a 
Gaussian shell size distribution was considered superimposed on the distribution 
obtained for bare Ni NPs and a sum was calculated for different particles having the 
same total diameter. The results of this procedure are shown in Table 1 and the 
recovered mean size are approximately 4 nm less than those obtained from intensity 
weighted size distributions, GI(d). The eventual effect of the ~2nm AOT or DOPG 
overcoat was not considered. 
Comparing the hydrodynamic diameter of Ni NPs with and without silica shell, it is 
possible to confirm the formation of the shell based on size increase with the 
[TEOS]/[Ni] ratio. Above [TEOS]:[Ni]=30:1, the increase of the shell size is smaller, 
which can be caused by the limited space of the water pools inside AOT reverse 
micelles (as already referred), that in fact control the particles size. Core/shell 
nanoparticles are generally more polydisperse, as inferred from a larger size 
distribution. 
The smallest particles, with hydrodynamic diameters in the order of 80 nm and narrow 
size distribution, were obtained from the synthesis of NPs (without silica shell) covered 
with a layer of the phospholipid DOPG. This shows that the lipid layer contributes to 
avoid particle aggregation and to reduce size and polydispersity. However, some degree 
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of aggregation is expected in these systems, as the lipid/surfactant layer is supposed to 
have the hydrophobic chains turned to the outer phase. 
 
Table 1. Hydrodynamic diameter (obtained by DLS) of Ni nanoparticles with and without silica shell, 
prepared by several synthesis methods. 
 
Ni NPs synthesis method [TEOS]:[Ni] 
Hydrodynamic diameter (nm) 
Intensity 
Distribution 
Number Distribution 
Core 
Shell 
thickness 
Aqueous CTAB solution 
TEOS added in AOT/cyclohexane 
0:1 88 ± 7 84 ± 7 --- 
10:1 157 ± 16 84 ± 7 34 ± 7 
30:1 175 ± 24 84 ± 7 42 ± 12 
60:1 185 ± 21 84 ± 7 48 ± 10 
Covered with one AOT layer 0:1 100 ± 9 95 ± 13 --- 
Covered with one DOPG layer 0:1 79 ± 6 76 ± 6 --- 
 
4.1.3. SEM microscopy 
Scanning Electron Microscopy (SEM) allow the direct observation of 2D projections of 
NPs structure, surface morphology and size. SEM images generally revealed 
nanoparticles with radius lower than 100 nm for almost all the synthesis methods 
employed. The NPs synthesized in CTAB aqueous solution revealed diameters between 
63.4 and 104 nm (Figure 4), with a size distribution of 66 ± 24 nm obtained from the 
histogram of image B. This result is slightly lower than the size distribution obtained 
from DLS measurements, indicating particle dimerization in aqueous media. Phase 
contrast SEM images (Figure 4C versus Figure 4D) confirmed that the particles 
obtained are metal nanoparticles.  
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Figure 4 - SEM images of nickel nanoparticles synthesized in CTAB aqueous solution with citric acid 
(1:0.75), at different amplifications. Inset: Particles size histogram of image B and fitting to a Gaussian 
distribution. 
 
 
 
Figure 5 - SEM images of nickel nanoparticles coated with silica shell. A: [TEOS]/[Ni]=5:1 (TEOS 
added in AOT/cyclohexane solution); B: [TEOS]/[Ni]=42:1 (TEOS added in ethanol solution with 
MDA). 
 
 
The increase in size of the shell is proportional to TEOS concentration and is dependent 
on the synthesis process (Figure 5). As referred, two processes were used for the coating 
with silica shell. In the first, TEOS was added in an AOT solution in cyclohexane, and 
the shell growth is controlled by the size of water pools of AOT reverse micelles. In the 
second, shell growth is not limited, as TEOS is added in ethanol together with a binding 
agent (MDA). A disadvantage of the first method is the low NPs concentration obtained 
(Figure 5A). As expected, the second method yields particles with a much larger silica 
shell, attaining more than 400nm diameter for high [TEOS]/[Ni] ratio (Figure 5B).  
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4.1.4. Magnetic Properties 
The magnetic properties of the nanoparticles synthesized in CTAB aqueous solution 
were characterized by measuring their corresponding magnetic hysteresis loop, which 
shows the relationship between the induced magnetic moment and the applied magnetic 
field (H). Figure 6 shows the hysteresis cycle measured on the prepared nickel 
nanoparticles. Typical ferromagnetic properties were observed, reaching the saturation 
at about 1 kOe (0.1T). The nickel nanoparticles exhibit some slight hysteresis (Figure 
6B), indicating an oxidation of the particles, with the formation of a NiO 
(antiferromagnetic) surface layer around the metallic particles. In fact, the obtained 
hysteresis loop (Figure 6A) is identical to the one previously reported for Ni NPs with a 
NiO layer [57]. The coercive field of the Ni NPs is 80 Oe (Figure 6B – point c) and is 
lower than the value reported, at room temperature, for NPs with NiO layer prepared by 
similar methods, which indicates a smaller amount of nickel oxidation on our prepared 
particles. 
In order to estimate the thickness of the NiO layer from the magnetic hysteresis cycles, 
the particles were considered to have a well ordered Ni core covered by a non-magnetic 
NiO shell (with thickness ) that acted as a magnetic “dead layer” [58]. In this respect, 
the measured saturation magnetization (Ms) of the particles is proportional to the 
volume fraction of the core, which carries the spontaneous magnetization. If the shell 
thickness δ is small, then the saturation magnetization can be determined, to first order, 
by [58] 
  







D
MM ss
6
10
          
(6) 
where D is the particle diameter and Ms0 is the saturation magnetization for a bulk Ni 
sample (Ms0 = 55 emu/g). Here, for particles with diameter of 84 nm and with Ms = 51.2 
emu/g, the obtained NiO layer thickness is =1.1 nm, which corresponds to about 3 unit 
cells. This shows that the synthesis of Ni particles using the cationic surfactant CTAB 
allows attaining an improvement of the NPs magnetic properties, relative to previous 
methods employing Triton X-100 as surfactant [57]. 
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Figure 6 - A: Magnetization hysteresis cycle of the nickel nanoparticles at room temperature. 
    B: Enlargement of the hysteresis loop of Figure 6A, in the low field region. 
 
 
3.2 Characterization of magnetoliposomes 
3.2.1. FRET assays in DMLs 
As described in the Experimental Section, two types of magnetoliposomes were 
synthesized, aqueous magnetoliposomes (AMLs) and dry magnetoliposomes (DMLs). 
In DMLs, clusters of magnetic nanoparticles were covered by the double chain 
surfactant AOT or the anionic phospholipid DOPG. The coating by a double lipid (or 
surfactant) layer was confirmed by FRET assays. The NDB labeled lipid NBD-C6-HPC, 
included in the second lipid layer of the DMLs, acts as energy donor, while the labeled 
lipid Rhodamine B-DHPE was included in the first lipid/surfactant layer, acting as 
energy acceptor. 
Figure 7 presents evidence for FRET occurrence between NBD and Rhodamine (Rh). 
Inset illustrates the spectral overlap between the emission of the donor (NBD) and the 
absorption of the acceptor (Rhodamine B), indispensable condition for FRET to occur. 
Fluorescence spectra of DMLs containing only donor or acceptor and DMLs containing 
both labeled lipids were measured, exciting only the donor NBD (λexc=465 nm), at the 
same dilution factor. As expected, characteristic NBD emission (λem=520 nm) is 
detected for DMLs labeled only with NBD-C6-HPC, while negligible fluorescence is 
observed for the DMLs containing only Rhodamine-DHPE. It is possible to verify that 
for DMLs with both donor and acceptor molecules, the emission in the NBD-C6-HPC 
region notably decreases, with a strong rise in the Rhodamine B region, proving the 
formation of the second lipid layer in DMLs. 
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Figure 7 – Fluorescence spectra (exc=465 nm, no Rhodamine excitation) of DMLs covered with AOT 
labeled with only NBD-C6-HPC (110
-2
 µM); DMLs labeled with only Rhodamine B-DHPE (110-2 µM) 
and DMLs labeled with both NBD-C6-HPC (110
-2
 µM) and Rhodamine B-DHPE (110-2 µM). Inset: 
Spectral overlap (spectra are normalized) between the fluorescence emission of the donor (NBD-C6-HPC) 
and the absorption of the acceptor (Rhodamine B-DHPE). 
 
Using the standard method, the fluorescence quantum yield of the donor in 
magnetoliposomes (in the absence of acceptor) was determined as D=0.185. FRET 
measurements revealed an energy transfer efficiency of 31%, with a corresponding 
donor-acceptor distance of 7.6 nm. Cell membrane has a typical thickness of 7 to 9 nm 
[59]. Therefore, these results clearly indicate that the labeled lipids Rhodamine B-
DHPE and NBD-C6-HPC are placed in the first and second lipid layer, respectively, in 
the structures formed. This confirms the structure of lipid bilayer around nickel 
nanoparticles and the synthesis of DMLs. 
 
3.2.2. SEM microscopy and DLS measurements 
Dry magnetoliposomes (DMLs) can be observed by SEM microscopy, as their structure 
does not present an inner water pool. On the contrary, the structure of aqueous 
magnetoliposomes (AMLs) is destroyed by the vacuum system used in SEM.  
The sizes of AMLs, prepared by using either DPPC or Egg-PC phospholipids, were 
determined by DLS (Table 2). The size of liposomes (without Ni NPs) is also shown, 
for comparison. 
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Table 2. Hydrodynamic diameter (obtained by DLS) of aqueous magnetoliposomes incorporating Ni NPs 
with and without silica shell. 
Phospholipid [TEOS]:[Ni] 
Hydrodynamic diameter (nm) 
Intensity 
distribution 
Number 
distribution 
(fixed shell of 5 nm 
thickness) 
Egg-PC 
without NPs 92 ± 10  90 ± 7 
0:1 103 ± 20 --- 
10:1 126 ± 33 --- 
20:1 135 ± 34 --- 
DPPC 
without NPs 115 ± 12 113 ± 9 
0:1 146 ± 34 --- 
20:1 175 ± 23 --- 
 
As previously reported, the size of Egg-PC liposomes is usually smaller than the one for 
DPPC liposomes prepared by the same technique (ethanolic injection) [60]. The results 
on Table 2 show that the presence of Ni nanoparticles contributes to a diameter increase 
relative to liposomes without NPs, this effect being more significant in DPPC 
magnetoliposomes.  
The entrapment of core/shell Ni/silica nanoparticles in liposomes contribute definitely 
to avoid particle aggregation, as the measured mean diameters are significantly lower 
for AMLs than for the corresponding nanoparticles (vd. Table 1). Comparing both lipid 
systems, the Egg-PC AMLs are more promising for applications in drug transport and 
delivery, considering their size and size distribution. 
SEM micrographs of DMLs of Ni nanoparticles covered by a double layer of the 
anionic surfactant AOT or of the phospholipid DOPG are presented in Figures 8 and 9, 
respectively. Figure 8B shows AOT DMLs with size varying between 58 and 76 nm, 
with a relatively low polydispersity. From the fit to a Gaussian distribution of the 
particles size histogram obtained from the image processing of Figure 8A (inset of 
Figure 8), a particle diameter of 67 ± 26 nm was calculated. DLS measurements allowed 
to determine a hydrodynamic diameter of 115 ± 26 nm, pointing to extended aggregation 
in aqueous media.  
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Figure 8 - SEM images of dry magnetoliposomes of nickel nanoparticles (without silica shell) covered by 
an AOT surfactant double layer. Inset: Particles size histogram of image A and fitting to a Gaussian 
distribution. 
 
  
Figure 9 - SEM images of dry magnetoliposomes of nickel nanoparticles covered by a DOPG lipid 
bilayer. Inset: Particles size histogram of image A and fitting to a Gaussian distribution. 
 
 
SEM results revealed that the DOPG DMLs are approximately monodisperse (Figure 
9B), with size around 76 nm. The fit to a Gaussian distribution of the particles size 
histogram obtained from SEM images (Figure 9A) allowed determining a diameter of 
65 ± 28 nm. DLS measurements revealed one population with a hydrodynamic diameter 
of 98 ± 16 nm, pointing again to some dimerization in aqueous media.  
These results are promising for future application of DMLs as drug transport/delivery 
systems, specially the DOPG-based system, as its size is below 100 nm with a narrow 
size distribution. 
3.3 Interaction of magnetoliposomes with giant unilamellar vesicles (GUVs) 
Non-specific interactions of the aqueous magnetoliposomes (AMLs) with giant 
unilamellar vesicles (GUVs), models of cell membranes, were also evaluated by FRET. 
For that purpose, the labeled lipid NBD-C6-HPC was included in Egg-PC AMLs, acting 
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as energy donor, while the hydrophobic probe Nile Red, also incorporated in AMLs, 
acts as acceptor.  
Nile Red is a well-known solvatochromic probe, which in polar media exhibits a red 
shift in the emission maximum, together with fluorescence quenching. Owing to its 
capability to establish H-bonds with protic solvents, Nile Red fluorescence in water is 
very weak and red shifted (max ~ 660 nm) [61]. Nile Red has been used as a lipid 
probe, due to its hydrophobic nature [62-65]. 
The significant overlap between NBD-C6-HPC emission band and Nile Red absorption 
spectrum (Figure 10 – inset) indicates that FRET process between these two fluorescent 
molecules is expected to be efficient, if the donor-acceptor distance is below 100 Å 
[39]. In fact, when both fluorophores are incorporated in magnetoliposomes at 
appropriate surface densities, efficient energy transfer is observed, exciting only the 
donor (NBD) (Figure 10). Two fluorescence bands are observed, the first (max=535 
nm) corresponding to NBD-C6-HPC emission and the second one to Nile Red, with 
maximum at 630 nm. This second band arises from the energy transfer of excited NBD 
molecules to Nile Red. When the magnetoliposomes interact with GUVs, if fusion 
occurs, a larger membrane is formed [66]. This leads to an increase in the donor-
acceptor distance and a corresponding decrease in the energy transfer efficiency from 
the NBD moieties, as is experimentally observed.  
 
Figure 10 – Fluorescence spectra (exc=400 nm) of AMLs of Egg-PC and Ni/silica core/shell NPs 
containing both NBD-C6-HPC (10
-6 
M) and Nile Red (210-6 M), before and after interaction with GUVs. 
Inset: Spectral overlap (spectra are normalized) between the fluorescence emission of the donor (NBD-
C6-HPC) and the absorption of the acceptor (Nile Red). 
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These experimental results are consistent with membrane fusion between the AMLs and 
GUVs. This process of membrane fusion is illustrated in Figure 11.  
Thus, a proof-of-concept is presented in this work, allowing to conclude that both 
aqueous and dry magnetoliposomes may be used as drug transport and delivery systems, 
as they can be guided with a magnetic field and can release the encapsulated drugs by 
fusion with the cell membrane. 
 
Figure 11 – Schematic illustration of the fusion between the GUVs and magnetoliposomes labeled with 
both NBD-C6-HPC and Nile Red. 
 
4. Conclusions 
In this work, magnetic nickel nanoparticles were successfully synthesized using 
microheterogeneous templating media.  
SQUID measurements of Ni NPs synthesized in CTAB aqueous solution allowed to 
determine a coercive field of 80 Oe.  
Nickel nanoparticles were successfully encapsulated into liposomes, forming aqueous 
(AMLs) or dry magnetoliposomes (DMLs). DMLs with AOT surfactant or DOPG 
double chain present low polydispersity and mean diameter lower than 100 nm, 
essential for in vivo applications. FRET measurements point to membrane fusion 
between the magnetoliposomes and models of cell membranes (GUVs). 
These results may be important for future drug delivery applications of antitumor drugs 
using magnetoliposomes for encapsulation and transport of antitumor drugs and taking 
advantage of the possibilities of hyperthermia.  
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